Concepedia

Author

Kerstin Kapp

Mologen (Germany)

Also Known As

Dale Shepard, Kapp Kerstin, Kapp, Kerstin, Kerstin Kapp

32

Publications

232

Citations

9

H-Index

27

Concepts

All Affiliations

Mologen (Germany)Hospital zum Heiligen GeistCharité - Universitätsmedizin BerlinFreie Universität Berlin
KK

About

Kerstin Kapp is an author at Mologen (Germany) specializing in immunology, medicine, and immunotherapy.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

5

5

120

2

Immunology

5

5

120

3

Cell Biology

3

3

83

4

Pharmacology

1

1

22

5

Autoimmune Disease

1

1

29

Kerstin Kapp

×

8

Publications

174

Citations

8

H-Index

YearCitations

Beneficial modulation of the tumor microenvironment and generation of anti-tumor responses by TLR9 agonist lefitolimod alone and in combination with checkpoint inhibitors

Kerstin Kapp, Barbara Volz, Detlef Oswald,

OncoImmunology

2019

42

Modulation of systemic antigen‐specific immune responses by oral antigen in humans

Kerstin Kapp, Jochen Maul, Arwed Hostmann,

European Journal of Immunology

2010

31

Genuine Immunomodulation With dSLIM

Kerstin Kapp, Christiane Kleuss, Matthias Schroff,

Molecular Therapy — Nucleic Acids

2014

29

Immune response induced by a linear DNA vector: Influence of dose, formulation and route of injection

Anne Endmann, Michael M. Baden, Elena Weisermann,

Vaccine

2010

22

Cationic Lipid-Formulated DNA Vaccine against Hepatitis B Virus: Immunogenicity of MIDGE-Th1 Vectors Encoding Small and Large Surface Antigen in Comparison to a Licensed Protein Vaccine

Anne Endmann, Katharina Klünder, Kerstin Kapp,

PLoS ONE

2014

15

Dendritic cells from human mesenteric lymph nodes in inflammatory and non‐inflammatory bowel diseases: subsets and function of plasmacytoid dendritic cells

Arwed Hostmann, Kerstin Kapp, Marianne Beutner,

Immunology

2012

12

Targeting of the WT191–138 fragment to human dendritic cells improves leukemia-specific T-cell responses providing an alternative approach to WT1-based vaccination

Nergui Dagvadorj, Anne Deuretzbacher, Daniela Weisenberger,

Cancer Immunology Immunotherapy

2016

12

Distinct immunological activation profiles of dSLIM® and ProMune® depend on their different structural context

Kerstin Kapp, Jacqueline L. Schneider, Lisa Schneider,

Immunity Inflammation and Disease

2016

11

Page 1